OraSure Technologies to Host Second Quarter Financial Call
BETHLEHEM, Pa. – OraSure Technologies, Inc. (NASDAQ: OSUR) is poised to reveal its second quarter 2025 financial results through a conference call at 5 p.m. ET on August 5, inviting stakeholders to gain insights into its performance and developments.
Accessing the Earnings Call
A live webcast of the earnings conference call will be available on the investor relations section of OraSure’s official website. Interested participants should plan to access the link and follow the prompts for registration at least 10 minutes before the scheduled start time. The webcast will also be archived for approximately one year, providing ongoing access to insights shared during the call.
Engaging with OraSure
For those eager to ask questions during the call, OraSure provides a pre-registration link. This process ensures that participants receive access details via email, enhancing engagement during the event.
About OraSure Technologies
OraSure Technologies, Inc., also known as OTI, stands at the forefront of healthcare innovation. The company is dedicated to transforming health by providing actionable insights and enhancing access to essential healthcare services. With a focus on ease of testing and sample management, OTI produces rapid diagnostic tests and collection devices aimed at identifying critical medical conditions. Its extensive product portfolio caters to various sectors, including clinical laboratories, hospitals, physician's offices, and direct-to-consumer markets, thus broadening its impact globally.
Key Offerings and Innovations
OTI continually strives to improve the quality and value of healthcare through innovation. They are committed to developing technologies that not only streamline testing processes but also empower individuals to take control of their health. With subsidiaries such as DNA Genotek Inc. and Sherlock Biosciences, OTI solidifies its position as a leader in healthcare diagnostics.
Investor and Media Contacts
For further inquiries, investors can reach out to Jason Plagman, VP of Investor Relations, via email. For media-related questions, Amy Koch, Director of Corporate Communications, is available for assistance. Their commitment to open communication ensures that stakeholders remain informed.
Frequently Asked Questions
What is the date of the earnings call for Q2 2025?
The earnings call is scheduled for August 5, 2025, at 5 p.m. ET.
How can I access the earnings call?
Access will be available through the investor relations page on OraSure's website, where a live webcast will be hosted.
Will the earnings call be recorded?
Yes, the webcast will be archived for approximately one year after the call.
Who can I contact for investor relations inquiries?
For investor relations, you can contact Jason Plagman at investorinfo@orasure.com.
What is OraSure's mission?
OraSure’s mission is to transform health through actionable insights and improve access to quality healthcare with innovative testing solutions.
